NHS National Framework for Transition products (Axitinib and Eltrombopag)
What the buyer wrote
Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025 Offer reference number: CM/TNS/25/5722 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5722/01 Axitinib and Eltrombopag Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months) Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months) Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Please note that the contract had…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NHS National Framework for Transition products (Axitinib and Eltrombopag)
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Work starts
- 30 Sep 2025
- Work ends
- 31 Jan 2027
- Where
- in the North East, in the North West, in the East Midlands, in the West Midlands, in the East of England, in the South East, in the South West, in Yorkshire and The Humber
- Kind of work
- Pharmacy and medicines
Who the buyer named
The buyer published a contact address on this notice. Questions closed on 27 Jun 2025, 13:00 BST.